EBVA page dedicated to the scientific research and academic study of EBV.
EBVEBV: The finding of what became known as EBV (Epstein et al., 1964) led to a whole new area in virology with important implications for viral carcinogenesis, immunology, and later even the treatment and prevention of certain human malignancies. Since the early days of EBV research, interest in EBV has undergone great changes as attested by the regular cycle of international meetings dealing with many aspects of EBV, by the great and increasing number of publications devoted to EBV each year.
Suggested reading: Epstein-Barr Virus: Latency and Transformation
In primary infection, Epstein-Barr Virus (EBV) replicates in oro-pharyngeal epithelial cells and establishes Latency III, II, and I infections in B-lymphocytes. EBV latent infection of B-lymphocytes is necessary for virus persistence, subsequent replication in epithelial cells, and release of infectious virus into saliva. EBV Latency III and II infections of B-lymphocytes, Latency II infection of oral epithelial cells, and Latency II infection of NK- or T-cell can result in malignancies, marked by uniform EBV genome presence and gene expression. Because of the marked CD4+ and CD8+ T-cell response to EBV nuclear proteins in Latency III infected B-lymphocytes, EBV associated lymphoid malignancies are most common in immune compromised people, whereas EBV associated Latency II infected anaplastic Nasopharyngeal Carcinoma is not more common in immune compromised people and is most common in otherwise normal Southestern Chinese people. This introduction highlights key aspects of what has been learned over the past 45 years about the role of EBV Latent infection associated gene expression in maintaining EBV episomes in dividing cells and in increasing cell growth and survival. We expect that a clear view of the current picture and access to more detailed references can be useful for applying new experimental approaches. A new book by Erle S. Robertson, Epstein-Barr Virus: Latency and Transformation, is intended to fulfill those missions.
Epstein-Barr Virus Book
Epstein-Barr Virus Vaccines
Epstein-Barr Virus Genome
Current Issues in Molecular Biology
- Metagenomics of the Microbial Nitrogen Cycle
- Pathogenic Neisseria
- Human Pathogenic Fungi
- Applied RNAi
- Molecular Diagnostics
- Phage Therapy
- Bioinformatics and Data Analysis in Microbiology
- The Cell Biology of Cyanobacteria
- Pathogenic Escherichia coli
- Campylobacter Ecology and Evolution